These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 8815576)

  • 1. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP; Castellino FJ
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
    Geng JP; Cheng CH; Castellino FJ
    Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
    Iakhiaev AV; Rezaie AR; Idell S
    Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation.
    Preston RJ; Villegas-Mendez A; Sun YH; Hermida J; Simioni P; Philippou H; Dahlbäck B; Lane DA
    FEBS J; 2005 Jan; 272(1):97-108. PubMed ID: 15634335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va.
    Gale AJ; Griffin JH
    Proteins; 2004 Feb; 54(3):433-41. PubMed ID: 14747992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
    Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
    Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation.
    Váradi K; Siekmann J; Turecek PL; Schwarz HP; Marder VJ
    Thromb Haemost; 1999 Dec; 82(6):1673-9. PubMed ID: 10613654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.
    Jalbert LR; Chan JC; Christiansen WT; Castellino FJ
    Biochemistry; 1996 Jun; 35(22):7093-9. PubMed ID: 8679535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
    Dahlbäck B; Villoutreix BO
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiologie and cellular regulation of the protein C system].
    Vincenot A; Gaussem P
    Ann Biol Clin (Paris); 1997; 55(1):17-24. PubMed ID: 9099247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the endothelial protein C receptor gene and thrombophilia.
    Medina P; Navarro S; Estellés A; España F
    Thromb Haemost; 2007 Sep; 98(3):564-9. PubMed ID: 17849044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells.
    Borrell M; Sala N; de Castellarnau C; Lopez S; Gari M; Fontcuberta J
    Thromb Haemost; 1992 Sep; 68(3):268-72. PubMed ID: 1440490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
    Grey ST; Hancock WW
    J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.